期刊： THROMBOSIS RESEARCH, 2022; 209 ()
SARS-CoV-2 vaccines have been carefully developed and significantly alleviate the global pandemic. However, a rare but severe complication after vacci......
期刊： THROMBOSIS RESEARCH, 2022; 211 ()
Objectives: Venous thromboembolism (VTE) is a common health problem, causing considerable morbidity and mortality. The incidence of VTE is higher in p......
期刊： THROMBOSIS RESEARCH, 2022; 214 ()
Introduction: Excessive activation of the coagulation cascades leads to life-threatening disseminated intravascular coagulation (DIC) in sepsis. Two r......
期刊： THROMBOSIS RESEARCH, 2022; 216 ()
Background: There has been a lack of research in the past on the prevalence and risk factors associated with deep vein thrombosis (DVT) in patients wi......
期刊： THROMBOSIS RESEARCH, 2022; 217 ()
Ranging from bleeding to thrombosis, the clinical features of congenital fibrinogen qualitative disorders, including dysfibrinogenemia and hypodysfibr......
期刊： THROMBOSIS RESEARCH, 2022; 209 ()
Background: This study aims to validate the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in Chinese patients with atrial fib......
期刊： THROMBOSIS RESEARCH, 2022; 213 ()
Introduction: As the most commonly used FVIII concentrate in China, the individualized pharmacokinetics (PK) and clinical outcomes of Kovaltry (BAY81-......
期刊： THROMBOSIS RESEARCH, 2022; 216 ()
Background: The optimal P2Y12 inhibitor in high bleeding risk (HBR) patients with acute coronary syndrome (ACS) remains unclear. We compared the in-ho......
期刊： THROMBOSIS RESEARCH, 2022; 218 ()
Background: Endotheliopathy and coagulopathy appear to be the main causes for critical illness and death in patients with coronavirus disease 2019 (CO......
期刊： THROMBOSIS RESEARCH, 2022; 210 ()
Introduction: Acute promyelocytic leukemia (APL) is often accompanied by potentially fatal coagulopathy, especially in high-risk APL. Bleeding, partic......
期刊： THROMBOSIS RESEARCH, 2022; 220 ()
Vaccination is the most cost-effective means of preventing and even eliminating infectious diseases. However, adverse reactions after vaccination are ......
期刊： THROMBOSIS RESEARCH, 2022; 219 ()
Background: Deep vein thrombosis (DVT) with its major complication, pulmonary embolism, is a global health problem. Endothelial dysfunction is involve......
期刊： THROMBOSIS RESEARCH, 2022; 213 ()
Introduction: Refractory or recurrent immune thrombocytopenia (ITP) patients suffer from the dual threat of high mortality and drug toxicity in additi......
期刊： THROMBOSIS RESEARCH, 2022; 210 ()
Introduction: Purpura fulminans (PF) is a hematological emergency that can be caused by severe congenital protein C (PC) deficiency. It has been rarel......
期刊： THROMBOSIS RESEARCH, 2022; 211 ()
Background: Deep vein thrombosis (DVT) is a serious venous thromboembolism and leads the morbidity and mortality worldwide. Circular RNAs (circRNAs) s......
